Isolation, drying & packaging will be performed in dedicated rooms.
The building will have secured access for personnel and will integrate the most up-to-date SHE regulations.
This new investment comes in line with our strategy to stay a leader in handling of highly potent and cytotoxic compounds. We offer a full integrated service to our customers to support their GMP development & manufacturing of highly potent intermediates and APIs at all development stages.